Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 10/20 | 0.63 |
| ▸ | AKT2 | P31751 | 4/20 | 0.63 |
| ▸ | AKT3 | Q9Y243 | 4/20 | 0.63 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.63 |
| ▸ | PRKCA | P17252 | 3/20 | 0.63 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.63 |
| ▸ | PRKCB | P05771 | 2/20 | 0.63 |
| ▸ | PRKACA | P17612 | 2/20 | 0.63 |
| ▸ | PRKACB | P22694 | 2/20 | 0.63 |
| ▸ | PKN1 | Q16512 | 2/20 | 0.63 |
| ▸ | PRKD2 | Q9BZL6 | 2/20 | 0.63 |
| ▸ | CIT | O14578 | 1/20 | 0.63 |
| ▸ | SGK1 | O00141 | 1/20 | 0.49 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.49 |
| ▸ | LATS1 | O95835 | 1/20 | 0.49 |
| ▸ | PRKCG | P05129 | 1/20 | 0.49 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.49 |
| ▸ | PRKCH | P24723 | 1/20 | 0.49 |
| ▸ | MARK3 | P27448 | 1/20 | 0.49 |
| ▸ | PRKCI | P41743 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16224054 | 0.99 | AKT1 (0.62) | AKT1AKT2AKT3ROCK1PRKCA | |
| SCHEMBL15810194 | 0.93 | AKT1 (0.62) | AKT1AKT2AKT3ROCK1PRKCA | |
| SCHEMBL15809898 | 0.93 | AKT1 (0.56) | AKT1AKT2AKT3ROCK1PRKCA | |
| SCHEMBL15810090 | 0.92 | AKT1 (0.55) | AKT1AKT2AKT3ROCK1PRKCA | |
| SCHEMBL15810078 | 0.91 | AKT1 (0.59) | AKT1AKT2AKT3ROCK1PRKCA | |
| SCHEMBL15810190 | 0.91 | ROCK1 (0.53) | AKT1AKT2AKT3ROCK1PRKCA | |
| SCHEMBL15810056 | 0.91 | AKT1 (0.51) | AKT1AKT2AKT3ROCK1PRKCA | |
| SCHEMBL15810149 | 0.90 | AKT1 (0.50) | AKT1AKT2AKT3ROCK1PRKCA | |
| SCHEMBL15810043 | 0.90 | AKT1 (0.62) | AKT1AKT2AKT3ROCK1PRKCA | |
| SCHEMBL15810154 | 0.88 | AKT1 (0.48) | AKT1AKT2AKT3ROCK1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3052098-B1 | ENZALUTAMIDE IN COMBINATION WITH AFURESERTIB FOR THE TREATMENT OF PROSTATE CANCER | NOVARTIS AG (CH) | 2020-12-02 | — | — | EP | claimed |
| EP-2663189-B1 | COMBINATION OF BORTEZOMIB WITH AFURESERTIB AND USE THEREOF IN THE TREATMENT OF CANCER | NOVARTIS AG (CH) | 2018-07-04 | — | — | EP | claimed |
| EP-2572199-B1 | COMBINATION | NOVARTIS AG (CH) | 2017-03-08 | — | — | EP | claimed |
| EP-2117523-B1 | INHIBITORS OF AKT ACTIVITY | GLAXOSMITHKLINE LLC (US) | 2014-06-25 | — | — | EP | claimed |
| EP-4242206-A1 | CRYSTALLINE N-{(1-S)-2-AMINO-1-[(3-FLUOROPHENYL)METHYL]ETHYL}-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-2-THIOPHENECARBOXAMIDE HYDROCHLORIDE | Novartis AG (CH) | 2023-09-13 | — | — | EP | disclosed |
| EP-2400964-A4 | CRYSTALLINE N-{(1-S)-2-AMINO-1-[(3-FLUOROPHENYL)METHYL]ETHYL}-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-2-THIOPHENECARBOXAMIDE HYDROCHLORIDE | GLAXOSMITHKLINE LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2400964-A1 | CRYSTALLINE N-{(1-S)-2-AMINO-1-[(3-FLUOROPHENYL)METHYL]ETHYL}-5-CHLORO-4-(4-CHLORO-1-METHYL-1H-PYRAZOL-5-YL)-2-THIOPHENECARBOXAMIDE HYDROCHLORIDE | GlaxoSmithKline LLC (US) | 2012-01-04 | — | — | EP | disclosed |